Kobby Finkelstein

Kobby Finkelstein has held various roles in the finance industry. Kobby started their career in 1998 as a Fund Manager at Dikla Mutual Funds (FIBI) and later moved to Moritz-Tuchler as a Fund Manager in 2000. In 2001, they joined Investec (Israel) as an Analyst, Head of Research, and Head of Derivatives Advisory & Underwriting. In 2004, they became the Head of International Investments at Meitav Dash - Provident and Pension Funds, where they worked until 2014. Since 2014, Kobby has been serving as the Chief Investment Officer at Neopharm Group.

Kobby Finkelstein has a strong education background in the field of finance and economics. Kobby attended Bar-Ilan University from 1991 to 1994, where they earned a Bachelor of Arts degree in Economics with Magna Cum Laude honors. Later, from 1994 to 1997, they pursued a Master of Business Administration degree in Finance at the same institution, again achieving Magna Cum Laude honors. In 2007, Kobby Finkelstein furthered their education by attending the CFA Institute, where they completed the Chartered Financial Analyst program from 2007 to 2009.